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SUMMARY
The origins of individual fat depots are not well understood, and thus, the availability of tools useful for studying depot-specific adipose
tissue development and function is limited. Cre drivers that selectively target only brown adipocyte, subcutaneous white adipocyte, or
visceral white adipocyte precursors would have significant value because they could be used to selectively study individual depots
without impacting the adipocyte precursors or intrinsic metabolic properties of the other depots. Here, we show that the majority of
the precursor and mature subcutaneous white adipocytes in adult C57Bl/6 mice are labeled by Prx1-Cre. In sharp contrast, few to no
brown adipocytes or visceral white adipocytes are marked by Prx1-Cre. This suggests that Prx1-Cre-mediated recombinationmay be use-
ful formaking depot-restricted geneticmanipulations in subcutaneous white adipocyte precursor cells, particularly when targeting genes
with fat-specific functions.
INTRODUCTION
Obesity is a risk factor for type 2 diabetes, dyslipidemia, car-
diovascular disease, and many other conditions including
cancer; however, not all fat depots are metabolically equal
(Peirce et al., 2014; Tchkonia et al., 2013). For example,
visceral obesity generally places individuals at a greater
risk for metabolic complications compared with subcu-
taneous obesity. Exactly why depot-specific metabolic dif-
ferences exist is a topic of great interest and importance.
Adipose tissue function can be studied genetically in mice
by a conditional gene knockout strategywith the adiponec-
tin-Cre driver, which globally targets mature white and
brown adipocytes (Berry and Rodeheffer, 2013; Eguchi
et al., 2011; Lee et al., 2013; Sanchez-Gurmaches and
Guertin, 2014). However, it has been more difficult to
genetically study depot-specific adipose tissue functions,
particularly in white fat, because tools to selectivelymanip-
ulate gene expression in subcutaneous versus visceral white
adipocytes are lacking.
An important advance in studying adipose tissue growth
was establishing techniques to isolate adipocyte progenitor
cells (APCs) from mice. APCs reside in the stromal vascular
fractions (SVFs) and are separated from non-adipose precur-
sors (e.g., endothelial progenitors, T cells, B cells, macro-
phages, etc.) using cell surface markers (CD31; CD45
(Lin); CD29+; CD34+; SCA1+; Joe et al., 2009; Rodeheffer
et al., 2008; Schulz et al., 2011). APCs can be further sepa-
rated into a CD24+ and CD24 population, both of which
are adipogenic in vitro, but only the CD24+ population re-
constitutes a functional fat padwhen transplanted intoa lip-
odystrophicmouse (Rodeheffer et al., 2008), and thus it has
been suggested that the CD24+ subpopulation contains the
adipocyte progenitors. Elucidating how APCs are regulated
has important implications for understanding and treating
obesity.Moreover, APCs from subcutaneous fat are an abun-
dant source of stemcells for regenerativemedicine, and thus
the ability to purify, culture, and transplant them could lead
to novel cell-based therapies. It would therefore be of signif-
icant value to identify Cre drivers that could direct genetic
recombination in depot-specific manners.
We previously reported that precursor cells expressing the
Myf5-Cre knockin driver give rise to a subset of white adipo-
cytes in addition to brown adipocytes and skeletal muscle
(Hung et al., 2014; Sanchez-Gurmaches and Guertin, 2014;
Sanchez-Gurmaches et al., 2012; Tallquist et al., 2000). In
youngC57Bl/6mice, nearly all of the anterior subcutaneous
and retroperitoneal visceral white adipocytes are labeled
withMyf5-Cre whereas all posterior subcutaneous white ad-
ipocytes and all mesenteric and perigonadal visceral white
adipocytes are Myf5-Cre negative (Sanchez-Gurmaches
and Guertin, 2014). Consistently, Myf5-Cre also labels
many, but not all, of the APCs in the anterior subcutaneous
and retroperitoneal depots. A similar pattern is recapitulated
with Pax3-Cre inmost depotswith somenotable exceptions
including additional labeling ofmanyperigonadalwhite ad-
ipocytes inmale, but not female, mice (Sanchez-Gurmaches
andGuertin, 2014). These findings reveal anunexpected de-
greeofheterogeneitywith respect to theMyf5-Cre andPax3-
Cre labeling in white fat; however, the utility of using the
Myf5-Cre andPax3-Credrivers for in vivo geneticmanipula-
tion of white adipocyte precursors is limited because they
neither uniformly nor selectively target any adipocyte class
but rather appear to label adipocytes based on their anatom-
ical location (i.e., dorsal-anterior) and in addition target
some non-adipose tissues.
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To identify Cre drivers that might be useful for targeting
different adipocytes populations, we scanned the literature
for well-characterized Cre drivers that have propensity to
label adipocyte precursors and tested their ability to acti-
vate a reporter in different fat depots. One candidate was
paired related homeobox transcription factor 1 Cre (Prx1-
Cre) because it reportedly expresses in the mesenchymal
precursors of the limbs and head (Logan et al., 2002), was
recently reported to express in precursors of both brown
and white adipocytes (Calo et al., 2010), and because
PRX1 itself reportedly functions in adipogenesis (Du
et al., 2013). A very recent report by Krueger and colleagues
also indicates that Prx1-Cre labels inguinal subcutaneous
adipocyte precursors (Krueger et al., 2014). Here, we pro-
vide a detailed analysis of Prx1-Cre labeling in fat and other
tissues and show that Prx1-Cre labeling is largely restricted
among the fat depots to the precursor and mature subcu-
taneous white adipocytes. Furthermore, we show that
Prx1-Cre labeling of subcutaneous WAT is stable and that
Prx1-Cre also labels brite/beige adipocytes in subcutaneous
WAT. Finally, the utility of using Prx1-Cre and other Cre
drivers for lineage tracing, cell marking, and conditional
gene deletion in adipose tissue is discussed.
RESULTS
Prx1-Cre Labeling of Adipocyte Precursors
Prx1-Cre mice were crossed with the R26R-mTmG reporter
(Logan et al., 2002; Muzumdar et al., 2007), which is a dual
color labeling system that utilizes a membrane-targeted
eGFP reporter downstream of a floxed membrane-targeted
tdTomato reporter and stop cassette. This reporter is partic-
ularly useful for labeling mature adipocytes because they
are largely composed of lipid and have very little cyto-
plasm, making them less amenable to labeling with cyto-
plasmic reporters (Berry and Rodeheffer, 2013; Sanchez-
Gurmaches and Guertin, 2014). Previous studies using adi-
ponectin-Cre to drive R26R-mTmG reporter expression
indicate the reporter has high efficiency and specificity
(Berry and Rodeheffer, 2013; Jeffery et al., 2014; Sanchez-
Gurmaches and Guertin, 2014). In Prx1-Cre;R26R-mTmG
mice, all Cre+ cells and their descendants express mGFP
whereas all Creneg cells and their descendants express
tdTomato. Using these mice, we scanned for reporter
expression in precursor and mature adipocyte pools in all
major fat depots. The depots we examine are abbreviated
as follows: for white adipose tissues (WATs), anterior subcu-
taneous (asWAT), posterior subcutaneous (psWAT), retro-
peritoneal (rWAT), perigonadal (pgWAT), and mesenteric
(mWAT), and for brown adipose tissues (BATs), interscapu-
lar (iBAT), subscapular (sBAT), cervical (cBAT), perirenal
(prBAT), and periaortic (paBAT).
Using 6-week-old Prx1-Cre;R26R-mTmGmale and female
mice, we first asked whether mGFP reporter activity is
detectable in the APCs of any depots. We fractionated the
SVFs from the mature adipocytes in several depots and,
from the SVF fractions, isolated CD31;CD45(Lin);
CD29+;CD34+;SCA1+ cells (Figure 1A), which are highly en-
riched for APCs (Rodeheffer et al., 2008; Sanchez-Gurm-
aches et al., 2012). In males, 12.5% of the APCs in asWAT
are mGFP+, and similarly, the CD24+ and CD24 popula-
tions in this depot are 10.5% and 10.9% mGFP+, respec-
tively, whereas no mGFP+ signal was detectable in the
Lin+ pool (Figure 1B). In psWAT, the number of mGFP+ pre-
cursors is significantly greater, reaching nearly 75% in the
APC, CD24+, and CD24 pools again with nomGFP+ signal
detectable in the Lin+ pool (Figure 1C). Representative dot
plots and distribution plots of the APC populations are
shown in Figure S1. In contrast, fewmGFP+ cells are detect-
able inmale visceralWATdepots (rWATand pgWAT) or BAT
depots (iBATand sBAT; Figures 1D–1G). In femalemice, the
Prx1-Cre labeling pattern in the subcutaneous WAT APC
pool is similar to that in males: in asWAT, the mGFP+ pop-
ulation is slightly higher in the females at 21.4% and in
psWAT nearly identical to the males at 75.8%, with the
CD24+ and CD24 populations showing similar percent-
ages in each depot and all Lin+ cells being tdTomato+ (Fig-
ures 1B and 1C). The labeling pattern in female mice is also
largely similar to the males in visceral depots, except in
pgWAT, in which a small percentage of APCs are mGFP+
(Figure 1E). Thus, in both genders, Prx1-Cre activates re-
porter gene expression in most white adipocyte progeni-
tors in psWAT.
Prx1-Cre Labeling of Mature Adipocytes
To quantify the extent to which Prx1-Cre-labeled APCs
contribute to the mature adipocyte population, we exam-
ined each depot by confocal microscopy. In the asWAT,
the labeling pattern is heterogeneous (Figures 2A and 2B),
consistentwith themixedmGFP+and tdTomato+APClabel-
ing in this depot (Figure 1B).Notably, the labelingpattern in
asWAT varies with anatomical location; for example, the
dorsal region of the depot is tdTomato+ (Figure 2A), whereas
the ventral region of the depot contains a variegated
mixture of mGFP+ and tdTomato+ adipocytes (Figure 2B).
On the other hand, 96% of the adipocytes in psWAT are
mGFP+ (Figure 2C), which is consistent with the high per-
centage of mGFP+ APCs in this depot (Figure 1C). However,
because psWAT is roughly 1.5–2.0 times themass of asWAT,
these results indicate that most of the subcutaneous white
adipocytes are mGFP in Prx1-Cre;R26R-mTmGmice.
In contrast to the subcutaneous depots, 100%of themale
visceral white adipocytes in mWAT, rWAT, and pgWAT are
tdTomato+, indicating Prx1-Cre did not express in their
ancestry (Figures 2D–2F). Similarly, in females, 100% of
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the mWAT and rWAT adipocytes are also tdTomato+. How-
ever, in female pgWAT, a few mature adipocytes (4.7%) are
mGFP+, which reflects the small number of Prx1-Cre-
labeled APCs that we also detect in this depot (Figure 1E).
Nevertheless, these results indicate that, among the major
white fat depots, Prx1-Cre recombinase activity drives re-
porter expression in adipocytes that are largely restricted
to subcutaneous white fat.
Given that almost no brown APCs in iBAT and sBAT ex-
press mGFP in Prx1-Cre;R26R-mTmG mice, we expected
few if any mature brown adipocytes would be mGFP+.
Indeed, no mGFP+ brown adipocytes are detectable in
iBAT, sBAT, cBAT, or prBAT in either male or female Prx1-
Cre;R26R-mTmG (Figures 3A–3D). However, in paBAT,
mGFP is detectable in 64.3% and 62.2% of the cells in
males and females, respectively (Figure 3E). Thus, in most
major BAT depots, the brown adipocytes are not labeled
with Prx1-Cre; however, in one depot (paBAT), Prx1-Cre
marks the majority of the brown adipocytes.
Utility of Prx1-Cre for Targeting Subcutaneous Fat
To gauge the potential utility of using Prx1-Cre to selec-
tively target subcutaneous white adipocytes, we compared
themRNA expression ofmGFP between adipose tissues and
Figure 1. Prx1-Cre Labels Adipocyte Precursors in Subcutaneous White Fats
(A) SVF populations analyzed in the present study by flow.
(B–G) Number of tdTomato+ and mGFP+ APCs isolated from each of the indicated depots from 6-week-old Prx1-cre;R26R-mTmG males and
females (n = 3 per each sex; mean + SEM).
See also Figure S1.
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Figure 2. Prx1-Cre Labels Mature Subcutaneous White Adipocytes
(A–F) Representative images of the indicated WATs of 6-week-old Prx1-Cre;R26R-mTmG male and female mice (top insert, tdTomato;
bottom insert, mGFP). The number of tdTomato+ and mGFP+ mature white adipocytes in each depot is indicated in a graph at the left side of
each row (n = 3 per each sex; mean + SEM). For all panels, scale bar represents 50 mm.
See also Figure S2.
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non-adipose tissues as a measure of past or present Prx1-
Cre recombinase activity. Consistent with the imaging re-
sults, mGFP reporter expression among the fat depots is
highest in psWAT, with only asWAT and paBAT, as pre-
dicted, showing significantly higher expression above
background (Figure 4A). Among skeletal muscles, the level
Figure 3. Most Brown Adipocytes Are Not Labeled by Prx1-Cre
(A–E) Representative images of the indicated BATs of 6-week-old Prx1-Cre;R26R-mTmGmale and female mice (top insert, tdTomato; bottom
insert, mGFP). The number of tdTomato+ and mGFP+ mature brown adipocytes in each depot is indicated in a graph at the left side of each
row (n = 3 per each sex; mean + SEM). For all panels, scale bar represents 50 mm.
See also Figure S2.
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Figure 4. Prx1-Cre Targeting Shows a High Degree of Selectivity to Subcutaneous WAT
(A)mGFPmRNA expression in the indicated tissues. Dotted line indicates the background level of mGFP expression (defined as the level of
expression of mGFP in no-Cre mice; n = 3 mice; mean + SEM).
(B) Representative images of the indicated skeletal muscles from Prx1-cre;R26R-mTmG mice. For all panels, scale bar represents 50 mm.
(C) Representative images of the indicated WATs of 6-week-old Prx1-Cre;R26R-mTmG male mice treated with CL316,243 for 1 week (top
insert, tdTomato; bottom insert, mGFP; n = 3 mice; mean + SEM). For all panels, scale bar represents 50 mm.
See also Figures S3 and S4.
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of mGFP expression is generally low (Figure 4A); mGFP re-
porter fluorescence was not detectable in any mature mus-
cle fibers in the quadriceps or gastrocnemius muscles by
our direct imaging strategy (Figure 4B). Slightly higher
than baseline levels of mGFP expression were detected in
lung and brain tissue, indicating a few cells in these tissues
might also be marked by Prx1-Cre. Notably, we did not
detect significant Cre mRNA expression in any whole fat
depot (not shown), suggesting that Prx1-Cre recombinase
activity may be active in only a small number of cells or
that it was active before 6 weeks of age. We verified fat
depot identity by analyzing Ucp1 and Perilipin1 mRNA
expression. Ucp1 most highly expresses in BAT depots
with only a very low level of expression in asWAT and
psWATand little if any in the visceralWAT (Figure S2A). Per-
ilipin1 highly expresses in all of the fat depots (Figure S2B).
We also analyzed the mRNA expression of both splicing
variants of Prx1 (Prx1a and Prx1b) and the levels of Prx2,
the second member of the family of paired-related homeo-
box proteins. Prx1a highly expresses in subcutaneous WAT
(asWAT and psWAT) and in paBAT compared to visceral
WATand the other BAT depots (Figure S3A). The expression
level of Prx1b is also higher in subcutaneous WAT than in
the visceral depots (Figure S3B). Prx1a and Prx1b also ex-
press more highly in skeletal and cardiac muscle, even
though we cannot find evidence of Prx1-Cre-recombi-
nase-driven reporter expression in muscle or cardiac cells.
Prx2 expresses at similar levels in both subcutaneous and
visceral white fats (Figure S3C). Thus, Prx1 mRNA does
not precisely overlap withmGFPmRNA expression, which
could reflect differences in promoter or mRNA regulatory
elements (see Discussion). Nevertheless, Prx1-Cre-medi-
ated recombination is highly selective to subcutaneous
white adipocyte precursors and mature adipocytes.
Finally, we asked whether the Prx1-Cre labeling pattern is
stable or changes with age (6 months) or in mice treated for
1 week with the beta-adrenergic agonist CL316,243, which
induces browning. Neither age nor CL316,243 treatment
changes the percentage of mGFP+ versus tdTomato+ APCs
or mature adipocytes in any depot we examined (Figures
4C and S4; not shown). Notably, the multilocular cells that
form in the psWATof mice treated with CL316,243 express
UCP1 and are labeled with mGFP in the Prx1-Cre;R26R-
mTmGmice, indicating that Prx1-Cre does not distinguish
betweenwhite and brite/beige adipocytes in this depot (Fig-
ure 4C). Thus, the contribution of the Prx1-Cre-marked ad-
ipocytes to the adipocyte population appears to be stable.
DISCUSSION
Recently, Krueger et al. (2014) reported that Prx1-Cre labels
inguinal (posterior subcutaneous) white adipocyte precur-
sors. Taken together, our studies provide complimentary
evidence that, in themouse, Prx1-Cre transgene activity la-
bels adipocyte progenitors of subcutaneous white adipo-
cytes. In further support, a recent study using Prx1-Cre to
delete Ptpn11, which encodes SHP-2 phosphatase, notes
that subcutaneous adipose tissue is absent in Prx1-
Cre;Ptpn11 floxed mice (Lapinski et al., 2013), which is
consistent with another recent study reporting a role for
SHP-2 in adipogenesis (He et al., 2013). Thus, Prx1-Cre
may be useful for conditional gene knockout studies in
scWAT, especially when targeting genes with adipocyte-
specific functions. However, it is essential that any study
employing Prx1-Cre to target subcutaneous adipocytes
pay careful attention to osteoblasts and chondrocytes (Lo-
gan et al., 2002). Of note, another recent study finds that
Wt1-Cre selectively labels progenitors of visceral white ad-
ipocytes (Chau et al., 2014). Thus, comparative studies us-
ingWt1-Cre and Prx1-Cre, when used tomanipulate genes
encoding fat-specific regulators, could provide valuable
insight about visceral versus subcutaneous fat function.
It was previously reported that Prx1-Cre expresses in the
precursors of all brown and white adipocytes in 4- to 6-
week-old mice (Calo et al., 2010). This report did not indi-
cate which depots were examined, so we could not do a
perfect comparison. Nevertheless, neither our study nor
Krueger et al. (2014) detect broad labeling of precursor or
mature brown adipocytes. The differences between our
studies could reflect the use of different reporters or
possibly strain background differences (the mice in Calo
et al., 2010 are on a mixed background compared to the
C57Bl/6 background used here and in Krueger et al.,
2014). Labeling mature adipocytes with cytoplasmic re-
porters such as LacZ can also be less reliable than using
membrane-targeted reporters because adipocytes have lit-
tle cytoplasm, making it difficult to detect which cells ex-
press b-galactosidase (Berry et al., 2014; Berry and Rode-
heffer, 2013; Sanchez-Gurmaches and Guertin, 2014;
Sanchez-Gurmaches et al., 2012).
There are noteworthy comparisons between Prx1-Cre
and the Myf5-Cre and Pax3-Cre-labeling patterns in adi-
pose tissue (Sanchez-Gurmaches and Guertin, 2014). First,
in the asWAT, Prx1-Cre marks mature adipocytes in a
ventral to dorsal pattern. This labeling pattern is opposite
to the Myf5-Cre;R26R-mTmG and Pax3-Cre;R26R-mTmG
patterns in asWAT, in which cells label in a dorsal to ventral
gradient. Thus, one possibility is that Myf5-Cre/Pax3-Cre
and Prx1-Cre maymark two different adipocyte progenitor
pools that converge in asWAT. Second, Prx1-Cre labels a sig-
nificant number of periaortic brown adipocytes whereas
Myf5-Cre and Pax3-Cre do not (Sanchez-Gurmaches and
Guertin, 2014). paBAT may have an important role in dia-
betes and cardiovascular disease (Fitzgibbons and Czech,
2014; Fitzgibbons et al., 2011; Guilherme et al., 2008).
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These results are consistent with a model in which brown
adipocytes may arise from multiple origins. Finally, the
observation that Myf5-Cre, Pax3-Cre, and Prx1-Cre label
populations of both brown and white adipocytes suggests
some brown and white adipocytes may share a common
precursor, although further experiments are required to
verify this.
Interestingly, Prx1-Cre does not distinguish between
white (unilocular) and brite/beige (multilocular) adipo-
cytes induced by CL316,243 in the psWAT. Currently, it is
unclear as to whether brite/beige adipocytes arise de novo
fromprecursors of a different lineage or form frompreexist-
ing unilocular white adipocytes (Barbatelli et al., 2010; Lee
et al., 2015; Rosenwald et al., 2013; Wang et al., 2013). Our
results suggest that, at least after CL316,243 treatment, any
brite/beige adipocytes that might form de novo originate
from either the same Prx1-Cre precursor pool as the resi-
dent subcutaneous white adipocytes or they express Prx1-
Cre during differentiation. Recent studies suggest that it
is likely the case that the newly observed brown-like adipo-
cytes appearing in psWAT are being derived largely from
the preexisting Prx1-Cre-marked unilocular adipocytes
(Lee et al., 2015).
One interesting possibility is that Prx1-Cre marks a
progenitor pool in development that gives rise to a sub-
cutaneous white adipocyte lineage. However, there are
important caveats that need to be considered when in-
terpreting data generated from Cre-mediated cell
marking or lineage tracing. For example, whereas Cre-
Lox-based recombination is currently one of the best
methods for lineage tracing in mice (Kretzschmar and
Watt, 2012), this approach is strictly a measure of pro-
moter activity and does not provide any information
as to whether the endogenous gene products actually ex-
press in the early developmental precursors of adipocytes
and/or functionally contribute to adipose tissue develop-
ment. In addition, in reporter-based cell-marking/line-
age-tracing studies, in which multiple tissue types label
positive with a particular Cre driver, it cannot be deter-
mined whether the recombination occurred in a single
lineage or alternatively in multiple independent lineages
that give rise to the different tissues. Nor can it be deter-
mined when a constitutively active Cre driver first ex-
presses. This last caveat may be addressable with the
use of inducible Cre drivers, such as tamoxifen-inducible
CreER drivers. However, CreER drivers are limited in
many cases by their efficiency and because tamoxifen
reportedly has negative effects on fat (Liu et al., 2015).
The use of doxycycline-driven Cre drivers might offer a
better alternative (Hudak et al., 2014; Jiang et al., 2014;
Wang et al., 2013). For example, a recent study inducing
b-galactosidase in adipocytes with doxycycline reports
that brite/beige adipocytes in psWAT are generated by
de novo adipogenesis from an undefined APC pool
(Wang et al., 2013); however, other studies using induc-
ible drivers but different reporters find that psWAT brite/
beige adipocytes arise from existing white adipocytes,
suggesting more work is needed to optimize methods
of cell marking and lineage tracing in adipose tissue
(Lee et al., 2015; Rosenwald et al., 2013). Lastly, whereas
Myf5-Cre and Pax3-Cre are knockin alleles (i.e., the Cre
is driven from the endogenous Myf5 and Pax3 promoter)
and therefore more ideal for cell-labeling experiments,
the Prx1-Cre used here is a transgene, and thus posi-
tional elements might also influence promoter activity
for this driver.
In conclusion, we find that Prx1-Cre recombinase activ-
ity is highly selective to subcutaneous white adipocyte pre-
cursors, which may be useful for biologists aiming to
manipulate the activity of genes with fat-specific functions
selectively in subcutaneous WAT.
EXPERIMENTAL PROCEDURES
Mice
R26R-mTmG (stock 007676) and prx1-Cre (stock 005584) were
from Jackson Laboratories. Mice were housed in the Animal Med-
icine facilities of the UMMS in a room set at 22C and 45% humid-
ity under a daily 12 hr light/dark cycle. All animal experiments
were approved by the University of Massachusetts Medical School
animal care and use committee.
Tissue Harvest
Adipose tissues used were carefully dissected to avoid surrounding
tissue contamination. Adipose tissue notation used here was
described previously (Sanchez-Gurmaches and Guertin, 2014).
FACS Analysis and Confocal Microscopy
APC analysis by FACS and whole-mount confocal and muscle his-
tology were done as previously reported (Sanchez-Gurmaches and
Guertin, 2014).
Data Presentation
Data are presented asmean + SEM, unless stated otherwise. Graphs
were done using GraphPad Prism v6.0c. Per each experiment and
sex, three mice were analyzed.
See also Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2015.02.008.
ACKNOWLEDGMENTS
We thank the UMMS flow core and Dr. Marc R. Freeman and col-
leagues for imaging assistance. We thank the D.A.G. lab for valu-
able discussions and especially to Huawei Li for assisting with
548 Stem Cell Reports j Vol. 4 j 541–550 j April 14, 2015 j ª2015 The Authors
animal colony management. D.A.G. is supported by grants from
the NIH (R01DK094004) and the American Diabetes Association
(ADA113BS-066).
Received: November 26, 2014
Revised: February 11, 2015
Accepted: February 12, 2015
Published: March 19, 2015
REFERENCES
Barbatelli, G., Murano, I., Madsen, L., Hao, Q., Jimenez, M., Kris-
tiansen, K., Giacobino, J.P., De Matteis, R., and Cinti, S. (2010).
The emergence of cold-induced brown adipocytes in mouse white
fat depots is determined predominantly by white to brown adipo-
cyte transdifferentiation. Am. J. Physiol. Endocrinol. Metab. 298,
E1244–E1253.
Berry, R., and Rodeheffer, M.S. (2013). Characterization of the
adipocyte cellular lineage in vivo. Nat. Cell Biol. 15, 302–308.
Berry, R., Jeffery, E., and Rodeheffer, M.S. (2014). Weighing in on
adipocyte precursors. Cell Metab. 19, 8–20.
Calo, E., Quintero-Estades, J.A., Danielian, P.S., Nedelcu, S., Ber-
man, S.D., and Lees, J.A. (2010). Rb regulates fate choice and line-
age commitment in vivo. Nature 466, 1110–1114.
Chau, Y.Y., Bandiera, R., Serrels, A., Martı´nez-Estrada, O.M., Qing,
W., Lee, M., Slight, J., Thornburn, A., Berry, R., McHaffie, S., et al.
(2014). Visceral and subcutaneous fat have different origins and
evidence supports a mesothelial source. Nat. Cell Biol. 16,
367–375.
Du, B., Cawthorn, W.P., Su, A., Doucette, C.R., Yao, Y., Hemati, N.,
Kampert, S., McCoin, C., Broome, D.T., Rosen, C.J., et al. (2013).
The transcription factor paired-related homeobox 1 (Prrx1) in-
hibits adipogenesis by activating transforming growth factor-b
(TGFb) signaling. J. Biol. Chem. 288, 3036–3047.
Eguchi, J.,Wang, X., Yu, S., Kershaw, E.E., Chiu, P.C., Dushay, J., Es-
tall, J.L., Klein, U., Maratos-Flier, E., and Rosen, E.D. (2011). Tran-
scriptional control of adipose lipid handling by IRF4. Cell Metab.
13, 249–259.
Fitzgibbons, T.P., and Czech,M.P. (2014). Epicardial and perivascu-
lar adipose tissues and their influence on cardiovascular disease:
basic mechanisms and clinical associations. J. Am. Heart Assoc.
3, e000582.
Fitzgibbons, T.P., Kogan, S., Aouadi, M., Hendricks, G.M., Straub-
haar, J., and Czech, M.P. (2011). Similarity of mouse perivascular
and brown adipose tissues and their resistance to diet-induced
inflammation. Am. J. Physiol. Heart Circ. Physiol. 301, H1425–
H1437.
Guilherme, A., Virbasius, J.V., Puri, V., and Czech, M.P. (2008).
Adipocyte dysfunctions linking obesity to insulin resistance and
type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367–377.
He, Z., Zhu, H.H., Bauler, T.J., Wang, J., Ciaraldi, T., Alderson, N.,
Li, S., Raquil, M.A., Ji, K., Wang, S., et al. (2013). Nonreceptor
tyrosine phosphatase Shp2 promotes adipogenesis through
inhibition of p38 MAP kinase. Proc. Natl. Acad. Sci. USA 110,
E79–E88.
Hudak, C.S., Gulyaeva, O., Wang, Y., Park, S.M., Lee, L., Kang, C.,
and Sul, H.S. (2014). Pref-1 marks very early mesenchymal precur-
sors required for adipose tissue development and expansion. Cell
Rep. 8, 678–687.
Hung, C.M., Calejman, C.M., Sanchez-Gurmaches, J., Li, H., Clish,
C.B., Hettmer, S., Wagers, A.J., and Guertin, D.A. (2014). Rictor/
mTORC2 loss in the Myf5 lineage reprograms brown fat meta-
bolism and protects mice against obesity and metabolic disease.
Cell Rep. 8, 256–271.
Jeffery, E., Berry, R., Church, C.D., Yu, S., Shook, B.A., Horsley, V.,
Rosen, E.D., and Rodeheffer, M.S. (2014). Characterization of Cre
recombinase models for the study of adipose tissue. Adipocyte 3,
206–211.
Jiang, Y., Berry, D.C., Tang,W., andGraff, J.M. (2014). Independent
stem cell lineages regulate adipose organogenesis and adipose ho-
meostasis. Cell Rep. 9, 1007–1022.
Joe, A.W., Yi, L., Even, Y., Vogl, A.W., and Rossi, F.M. (2009).
Depot-specific differences in adipogenic progenitor abundance
and proliferative response to high-fat diet. Stem Cells 27, 2563–
2570.
Kretzschmar, K., and Watt, F.M. (2012). Lineage tracing. Cell 148,
33–45.
Krueger, K.C., Costa, M.J., Du, H., and Feldman, B.J. (2014).
Characterization of Cre recombinase activity for in vivo target-
ing of adipocyte precursor cells. Stem Cell Reports 3, 1147–
1158.
Lapinski, P.E., Meyer, M.F., Feng, G.S., Kamiya, N., and King, P.D.
(2013). Deletion of SHP-2 in mesenchymal stem cells causes
growth retardation, limb and chest deformity, and calvarial defects
in mice. Dis. Model. Mech. 6, 1448–1458.
Lee, K.Y., Russell, S.J., Ussar, S., Boucher, J., Vernochet, C., Mori,
M.A., Smyth, G., Rourk, M., Cederquist, C., Rosen, E.D., et al.
(2013). Lessons on conditional gene targeting in mouse adipose
tissue. Diabetes 62, 864–874.
Lee, Y.H., Petkova, A.P., Konkar, A.A., and Granneman, J.G. (2015).
Cellular origins of cold-induced brown adipocytes in adult mice.
FASEB J. 29, 286–299.
Liu, L., Zou, P., Zheng, L., Linarelli, L.E., Amarell, S., Passaro, A., Liu,
D., and Cheng, Z. (2015). Tamoxifen reduces fat mass by boosting
reactive oxygen species. Cell Death Dis. 6, e1586.
Logan, M., Martin, J.F., Nagy, A., Lobe, C., Olson, E.N., and Ta-
bin, C.J. (2002). Expression of Cre Recombinase in the devel-
oping mouse limb bud driven by a Prxl enhancer. Genesis 33,
77–80.
Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., and Luo, L.
(2007). A global double-fluorescent Cre reporter mouse. Genesis
45, 593–605.
Peirce, V., Carobbio, S., and Vidal-Puig, A. (2014). The different
shades of fat. Nature 510, 76–83.
Rodeheffer, M.S., Birsoy, K., and Friedman, J.M. (2008). Identifica-
tion of white adipocyte progenitor cells in vivo. Cell 135,
240–249.
Rosenwald, M., Perdikari, A., Ru¨licke, T., and Wolfrum, C. (2013).
Bi-directional interconversion of brite and white adipocytes. Nat.
Cell Biol. 15, 659–667.
Stem Cell Reports j Vol. 4 j 541–550 j April 14, 2015 j ª2015 The Authors 549
Sanchez-Gurmaches, J., and Guertin, D.A. (2014). Adipocytes arise
from multiple lineages that are heterogeneously and dynamically
distributed. Nat. Commun. 5, 4099.
Sanchez-Gurmaches, J., Hung, C.M., Sparks, C.A., Tang, Y., Li, H.,
and Guertin, D.A. (2012). PTEN loss in the Myf5 lineage redistrib-
utes body fat and reveals subsets of white adipocytes that arise
from Myf5 precursors. Cell Metab. 16, 348–362.
Schulz, T.J., Huang, T.L., Tran, T.T., Zhang, H., Townsend, K.L.,
Shadrach, J.L., Cerletti, M., McDougall, L.E., Giorgadze, N., Tchko-
nia, T., et al. (2011). Identification of inducible brown adipocyte
progenitors residing in skeletal muscle and white fat. Proc. Natl.
Acad. Sci. USA 108, 143–148.
Tallquist, M.D., Weismann, K.E., Hellstro¨m, M., and Soriano, P.
(2000). Early myotome specification regulates PDGFA expres-
sion and axial skeleton development. Development 127, 5059–
5070.
Tchkonia, T., Thomou, T., Zhu, Y., Karagiannides, I., Pothoulakis,
C., Jensen, M.D., and Kirkland, J.L. (2013). Mechanisms andmeta-
bolic implications of regional differences among fat depots. Cell
Metab. 17, 644–656.
Wang, Q.A., Tao, C., Gupta, R.K., and Scherer, P.E. (2013). Tracking
adipogenesis during white adipose tissue development, expansion
and regeneration. Nat. Med. 19, 1338–1344.
550 Stem Cell Reports j Vol. 4 j 541–550 j April 14, 2015 j ª2015 The Authors
